The Impact of COVID-19 Vaccination in Changing the Adherence to Preventive Measures: Evidence from Italy.
COVID-19
attitude
behaviors
preventive measures
vaccination
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
13 May 2022
13 May 2022
Historique:
received:
19
04
2022
revised:
09
05
2022
accepted:
10
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
The objectives of the survey were to explore any changes in the adherence to the three main COVID-19 preventive measures (social distancing, washing hands, wearing face-masks) among 795 individuals who received the COVID-19 vaccine booster dose in Italy and to identify the predictors associated. The concern of contracting COVID-19 before the vaccination, after the primary COVID-19 vaccine series, and after the booster dose resulted with a mean value of 7.7, 4.6, and 4.2, respectively. Females, those who had a lower mean self-perceived health status, who perceived COVID-19 as a very serious health problem, who decided to receive the booster dose because they perceived to be at risk of getting COVID-19, and who expressed interest in acquiring more information regarding the COVID-19 vaccine booster dose were more likely to report a higher concern of contracting COVID-19 after the booster dose. Over two-thirds were willing to respect the three main COVID-19 preventive measures following the booster dose. The multinomial logistic regression analysis showed that those who had used all three main preventive measures before and after the second or single dose were less likely to perceive COVID-19 as a serious illness. Those who had used them irregularly were less likely to have used official government organizations and scientific journals as sources of information. This survey provided an understanding regarding the adherence to COVID-19 preventive measures that may help to target policy interventions needed to reduce the spread of SARS-CoV-2.
Identifiants
pubmed: 35632533
pii: vaccines10050777
doi: 10.3390/vaccines10050777
pmc: PMC9143241
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Regione Campania
ID : Regione Campania
Références
Vaccines (Basel). 2022 Jan 19;10(2):
pubmed: 35214605
Vaccine. 2020 Nov 10;38(48):7668-7673
pubmed: 33071002
Transl Behav Med. 2021 Apr 7;11(3):793-801
pubmed: 33755146
PLoS One. 2022 Jan 12;17(1):e0261559
pubmed: 35020721
Hum Vaccin Immunother. 2022 Dec 31;18(1):2022920
pubmed: 35061569
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
Int J Ment Health Addict. 2022;20(1):83-91
pubmed: 32837428
J Epidemiol Community Health. 2022 Feb;76(2):109-115
pubmed: 34244309
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27285-27291
pubmed: 33060298
Hum Vaccin Immunother. 2020 Nov 1;16(11):2744-2751
pubmed: 32298210
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Build Environ. 2021 Dec;206:108367
pubmed: 34566244
Vaccines (Basel). 2021 Jan 19;9(1):
pubmed: 33477779
Vaccines (Basel). 2021 Jun 24;9(7):
pubmed: 34202867
Vaccine. 2021 Jun 16;39(27):3602-3607
pubmed: 34034950
Front Public Health. 2021 Jul 21;9:702699
pubmed: 34368065
Expert Rev Vaccines. 2021 Jul;20(7):881-889
pubmed: 33900148
Front Public Health. 2021 Dec 21;9:777426
pubmed: 34993170
Vaccines (Basel). 2021 Oct 04;9(10):
pubmed: 34696242
Psychol Health. 2022 Apr 22;:1-21
pubmed: 35459428
Int J Environ Res Public Health. 2021 Jun 06;18(11):
pubmed: 34204088
Vaccines (Basel). 2021 Mar 18;9(3):
pubmed: 33803730
Vaccines (Basel). 2021 Nov 03;9(11):
pubmed: 34835207
J Med Internet Res. 2021 Mar 8;23(3):e23231
pubmed: 33539309
Int J Ment Health Addict. 2022;20(3):1303-1310
pubmed: 33437224
Vaccine. 2021 Feb 12;39(7):1148-1156
pubmed: 33461834
PLoS One. 2021 Apr 26;16(4):e0250554
pubmed: 33901260